BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31919903)

  • 1. Evaluating symptom burden in kidney transplant recipients: validation of the revised Edmonton Symptom Assessment System for kidney transplant recipients - a single-center, cross-sectional study.
    Dano S; Pokarowski M; Liao B; Tang E; Ekundayo O; Li V; Edwards N; Ford H; Novak M; Mucsi I
    Transpl Int; 2020 Apr; 33(4):423-436. PubMed ID: 31919903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients.
    Tang E; Ekundayo O; Peipert JD; Edwards N; Bansal A; Richardson C; Bartlett SJ; Howell D; Li M; Cella D; Novak M; Mucsi I
    Qual Life Res; 2019 Mar; 28(3):815-827. PubMed ID: 30467780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Edmonton Symptom Assessment System in Korean patients with cancer.
    Kwon JH; Nam SH; Koh S; Hong YS; Lee KH; Shin SW; Hui D; Park KW; Yoon SY; Won JY; Chisholm G; Bruera E
    J Pain Symptom Manage; 2013 Dec; 46(6):947-56. PubMed ID: 23628516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Edmonton Symptom Assessment System including constipation and sleep: validation in outpatients with cancer.
    Hannon B; Dyck M; Pope A; Swami N; Banerjee S; Mak E; Bryson J; Rodin G; Ridley J; Lo C; Le LW; Zimmermann C
    J Pain Symptom Manage; 2015 May; 49(5):945-52. PubMed ID: 25523890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients.
    Paiva CE; Manfredini LL; Paiva BS; Hui D; Bruera E
    PLoS One; 2015; 10(7):e0132073. PubMed ID: 26154288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.
    Donlan J; Zeng C; Indriolo T; Li L; Zhu E; Zhou J; Pintro K; Horick N; Edelen M; Chung RT; El-Jawahri A; Ufere NN
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised.
    Yokomichi N; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Mori M; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2015 Nov; 50(5):718-23. PubMed ID: 26169339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric Properties of the Icelandic Version of the Revised Edmonton Symptom Assessment Scale.
    Gretarsdottir H; Fridriksdottir N; Gunnarsdottir S
    J Pain Symptom Manage; 2016 Jan; 51(1):133-7. PubMed ID: 26384555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spanish version of the Edmonton Symptom Assessment System-revised (ESAS-r): first psychometric analysis involving patients with advanced cancer.
    Carvajal A; Hribernik N; Duarte E; Sanz-Rubiales A; Centeno C
    J Pain Symptom Manage; 2013 Jan; 45(1):129-36. PubMed ID: 22926088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
    Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.
    Battaglia Y; Zerbinati L; Piazza G; Martino E; Provenzano M; Esposito P; Massarenti S; Andreucci M; Storari A; Grassi L
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32252326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up.
    Ripamonti C; Leporati R; De Feo G; Di Pede P; Toffolatti L; Guglielmo M; La Carpia D; Miccinesi G; Chiesi F
    Support Care Cancer; 2022 Mar; 30(3):1923-1933. PubMed ID: 34623487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kannada Translation and Validation of the ESAS-r Renal for Symptom Burden Survey in Patients with End-Stage Kidney Disease.
    Naik B; Nagaraju SP; Guddattu V; Salins N; Prabhu R; Damani A; Naik P; Rao KS; Rao IR; Singhai P
    Indian J Palliat Care; 2023; 29(2):195-199. PubMed ID: 37325264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric Validation of the Edmonton Symptom Assessment System in Chinese Patients.
    Dong Y; Chen H; Zheng Y; Guo Y; Kwon JH; Liu E; Guo H; Bruera E
    J Pain Symptom Manage; 2015 Nov; 50(5):712-17.e2. PubMed ID: 26386188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden.
    Davison SN; Jhangri GS; Johnson JA
    Kidney Int; 2006 May; 69(9):1621-5. PubMed ID: 16672923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients.
    Davison SN; Jhangri GS; Johnson JA
    Nephrol Dial Transplant; 2006 Nov; 21(11):3189-95. PubMed ID: 16957010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the feasibility of using the Edmonton Symptom Assessment System (ESAS) to assess caregiver symptom burden.
    Tanco K; Vidal M; Arthur J; Delgado Guay M; Hui D; Liu D; Chisholm G; Bruera E
    Palliat Support Care; 2018 Feb; 16(1):14-22. PubMed ID: 28264740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability and validity of a Thai version of the edmonton symptom assessment scale (ESAS-Thai).
    Chinda M; Jaturapatporn D; Kirshen AJ; Udomsubpayakul U
    J Pain Symptom Manage; 2011 Dec; 42(6):954-60. PubMed ID: 21621964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing Cutoff Points for Defining Symptom Severity Using the Edmonton Symptom Assessment System-Revised Japanese Version.
    Yamaguchi T; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2016 Feb; 51(2):292-7. PubMed ID: 26598039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.